HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MiCMA protocol

chemotherapy protocol consisting of above cpds; used for treatment of refractory or recurrent Hodgkin's disease

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MiCMA protocol: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MiCMA protocol: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MiCMA protocol: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Cytarabine: 6662
        MiCMA protocol: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        MiCMA protocol: 1
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - MiCMA protocol: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907
        MiCMA protocol: 1
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        Methylprednisolone: 7513
        MiCMA protocol: 1
Organic Chemicals: 133

Experts

1.	Bartolozzi, Francesco: 1 article (02/2006)
2.	Chiusolo, Patrizia: 1 article (02/2006)
3.	Laurenti, Luca: 1 article (02/2006)
4.	Leone, Giuseppe: 1 article (02/2006)
5.	Marra, Roberto: 1 article (02/2006)
6.	Piccirillo, Nicola: 1 article (02/2006)
7.	Sica, Simona: 1 article (02/2006)
8.	Sorá, Federica: 1 article (02/2006)

Related Diseases

1.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/15/2006 - "From September 1991 to August 2002, 94 consecutive patients ages 16-60 years who had either recurrent or refractory NHL (mainly diffuse large-cell lymphomas) were treated on the MiCMA protocol. "